Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -12.24% is 259% below its 5-year average of -3.41%, around the middle of its 5-year range (-23.08%–2.52%).
25.29% below its 12-month average of -9.77%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): -1.92%.
NET PROFIT MARGIN
-12.24%
NET PROFIT MARGIN AVG TTM
-9.77%
NET PROFIT MARGIN AVG 3Y
-3.86%
NET PROFIT MARGIN AVG 5Y
-3.41%
NET PROFIT MARGIN AVG 10Y
-3.53%
NET PROFIT MARGIN AVG 15Y
-5.56%
NET PROFIT MARGIN AVG 20Y
-4.30%
CURRENT VS TTM AVG
-25.29%
CURRENT VS 3Y AVG
-216.79%
CURRENT VS 5Y AVG
-259.13%
CURRENT VS 10Y AVG
-246.90%
CURRENT VS 15Y AVG
-120.30%
CURRENT VS 20Y AVG
-184.48%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Accuray Incorporated
Market Cap
$37.14M
Net Profit Margin
-12.24%
TTM Avg
-9.77%
3Y Avg
-3.86%
5Y Avg
-3.41%
Market Cap
$37.81M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-322.60%
Market Cap
$36.38M
Net Profit Margin
-65.29%
TTM Avg
-26.68%
3Y Avg
-11.11%
5Y Avg
-8.71%
Market Cap
$36.32M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
Market Cap
$38.31M
Net Profit Margin
0.00%
TTM Avg
-27258.72%
3Y Avg
-52085.61%
5Y Avg
-35139.97%
Market Cap
$35.82M
Net Profit Margin
426.93%
TTM Avg
106.45%
3Y Avg
-19.31%
5Y Avg
-30.13%
Market Cap
$35.58M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$38.90M
Net Profit Margin
-11.86%
TTM Avg
-39.34%
3Y Avg
-22.53%
5Y Avg
-16.34%
Market Cap
$34.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1673.30%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $37.14M | -12.24% | -9.77% | -3.86% | -3.41% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.81M | 0.00% | 0.00% | 0.00% | -322.60% |
| DocGo Inc. (DCGO)vs › | $36.38M | -65.29% | -26.68% | -11.11% | -8.71% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.32M | 0.00% | 0.00% | 0.00% | -479.12% |
| Incannex Healthcare Limited (IXHL)vs › | $38.31M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
| Elutia Inc (ELUT)vs › | $35.82M | 426.93% | 106.45% | -19.31% | -30.13% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.90M | -11.86% | -39.34% | -22.53% | -16.34% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.01M | 0.00% | 0.00% | 0.00% | -1673.30% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | -689.20% | -248.90% | -225.94% | -1945.52% |
Operating Margin
-6.6%
Net Profit Margin
-12.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1.92% |
| 2026-03-31 | -11.26% |
| 2025-12-31 | -13.47% |
| 2025-09-30 | -23.08% |
| 2025-06-30 | 0.88% |
| 2025-03-31 | -1.15% |
| 2024-12-31 | 2.18% |
| 2024-09-30 | -3.89% |
| 2024-06-30 | 2.52% |
| 2024-03-31 | -6.27% |
| 2023-12-31 | -8.97% |
| 2023-09-30 | -2.86% |
| 2023-06-30 | -2.16% |
| 2023-03-31 | 0.51% |
| 2022-12-31 | -1.63% |
| 2022-09-30 | -5.65% |
| 2022-06-30 | -3.14% |
| 2022-03-31 | -1.09% |
| 2021-12-31 | 0.15% |
| 2021-09-30 | -0.96% |
| 2021-06-30 | -10.00% |
| 2021-03-31 | -0.38% |
| 2020-12-31 | 4.89% |
| 2020-09-30 | 0.47% |
| 2020-06-30 | -0.16% |
| 2020-03-31 | 2.64% |
| 2019-12-31 | 10.84% |
| 2019-09-30 | -10.44% |
| 2019-06-30 | -1.19% |
| 2019-03-31 | -1.15% |
| 2018-12-31 | -4.53% |
| 2018-09-30 | -9.61% |
| 2018-06-30 | -0.83% |
| 2018-03-31 | -8.87% |
| 2017-12-31 | -4.70% |
| 2017-09-30 | -10.32% |
| 2017-06-30 | -4.69% |
| 2017-03-31 | -5.17% |
| 2016-12-31 | -10.71% |
| 2016-09-30 | -11.47% |
| 2016-06-30 | -7.59% |
| 2016-03-31 | 0.72% |
| 2015-12-31 | -5.53% |
| 2015-09-30 | -10.75% |
| 2015-06-30 | -5.50% |
| 2015-03-31 | -3.04% |
| 2014-12-31 | -10.18% |
| 2014-09-30 | -26.28% |
| 2014-06-30 | -9.62% |
| 2014-03-31 | -4.80% |
| 2013-12-31 | -5.81% |
| 2013-09-30 | -20.27% |
| 2013-06-30 | -22.04% |
| 2013-03-31 | -44.23% |
| 2012-12-31 | -37.50% |
| 2012-09-30 | -29.16% |
| 2012-06-30 | -20.16% |
| 2012-03-31 | -14.62% |
| 2011-12-31 | -9.76% |
| 2011-09-30 | -26.39% |
| 2011-06-30 | -33.21% |
| 2011-03-31 | -2.12% |
| 2010-12-31 | 7.55% |
| 2010-09-30 | -12.19% |
| 2010-06-30 | 8.12% |
| 2010-03-31 | 4.37% |
| 2009-12-31 | -2.05% |
| 2009-09-30 | -6.48% |
| 2009-06-27 | 2.08% |
| 2009-03-28 | 1.98% |
| 2008-12-27 | 2.34% |
| 2008-09-27 | -5.69% |
| 2008-06-28 | 0.37% |
| 2008-03-29 | 0.99% |
| 2007-12-29 | 4.50% |
| 2007-09-29 | 4.66% |
| 2007-06-30 | 1.14% |
| 2007-03-31 | -2.10% |
| 2006-12-30 | -27.67% |
| 2006-09-30 | 5.97% |
| 2006-06-30 | -47.90% |
| 2006-03-31 | -47.90% |
| 2005-12-31 | -47.90% |
| 2005-09-30 | -263.76% |
| 2005-06-30 | -112.57% |
| 2005-03-31 | -112.57% |
| 2004-12-31 | -112.57% |
| 2004-09-30 | -112.57% |
